RETATRUTIDE
RETATRUTIDE is a next-generation peptide currently under evaluation as a triple receptor agonist of GLP-1, GIP, and glucagon receptors. It has attracted significant attention in metabolic and obesity research models for its role in regulating appetite signaling, energy balance, and body composition.
In controlled clinical trials, RETATRUTIDE has been associated with:
-
Up to 24.2% average body weight reduction over 48 weeks in studied populations
-
Up to 86% liver fat reduction in NASH research models
Atlas Compounds provides RETATRUTIDE as a 5, 10, or 15mg lyophilized peptide, with confirmed purity ≥99% via HPLC.
CARE & MAINTENANCE
To ensure maximum potency and shelf life, store all peptides in a cool, dry place away from direct sunlight and heat.
Unreconstituted vials are best kept refrigerated at 2–8 °C.
Once reconstituted with bacteriostatic water, peptides must be stored in the refrigerator and used within 90 days.
Always handle vials with clean hands and sterile equipment to prevent contamination. Do not shake the vial—gently swirl to dissolve the powder.
If you notice any discoloration, cloudiness, or clumping, discard the vial immediately.
intended use
This product is strictly for laboratory research, education, and development purposes only.
Terms of Sale
By purchasing or handling this compound, you acknowledge that you are a qualified researcher or institution aware of the proper safety protocols.
Atlas Compounds assumes no liability for any misuse, mishandling, or off-label application of this product.
Disclaimer
All information provided is for educational and scientific reference only. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.